Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 6354
Publisher
MDPI AG
Online
2020-09-02
DOI
10.3390/ijms21176354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis
- (2019) Dong Hun Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Phage display screening of therapeutic peptide for cancer targeting and therapy
- (2019) Phei Er Saw et al. Protein & Cell
- Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases
- (2019) In Jun Yeo et al. PHARMACOLOGY & THERAPEUTICS
- Antibodies to watch in 2020
- (2019) Hélène Kaplon et al. mAbs
- Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma
- (2018) Yubing Wang et al. CANCER LETTERS
- Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer
- (2018) Qihan Fu et al. ONCOGENE
- Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer
- (2018) Nipaporn Ngernyuang et al. PATHOLOGY
- Potential suppressive effects of theophylline on human rectal cancer SW480 cells in�vitro by inhibiting YKL-40 expression
- (2018) Hong Peng et al. Oncology Letters
- Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis
- (2018) Do-Hyun Kim et al. Nature Communications
- K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression
- (2018) Ji Yeon Choi et al. Journal of Neuroinflammation
- Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1
- (2018) Ki Cheon Kim et al. Theranostics
- YKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells
- (2017) Te-Mao Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1
- (2017) N Cohen et al. ONCOGENE
- Role of chitinase-like proteins in cancer
- (2016) Julia Kzhyshkowska et al. BIOLOGICAL CHEMISTRY
- Corrigendum: IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses
- (2016) Chang-Min Lee et al. Nature Communications
- Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer
- (2015) J. S. Johansen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- RelB/p50 Complexes Regulate Cytokine-Induced YKL-40 Expression
- (2015) Reetika Bhardwaj et al. JOURNAL OF IMMUNOLOGY
- Pharmacokinetic properties of IgG and various Fc fusion proteins in mice
- (2015) Felix Unverdorben et al. mAbs
- Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9
- (2015) Daren Low et al. Oncotarget
- Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis
- (2014) Xiao-Wei Wang et al. TUMOR BIOLOGY
- Increased expression and possible role of chitinase 3-like-1 in a colitis-associated carcinoma model
- (2014) Jia-Yi Ma WORLD JOURNAL OF GASTROENTEROLOGY
- Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
- (2013) R. Shao et al. CARCINOGENESIS
- CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors
- (2013) Stephania Libreros et al. IMMUNOLOGIC RESEARCH
- Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2
- (2013) Chuan Hua He et al. Cell Reports
- Development of Anti-Infectives Using Phage Display: Biological Agents against Bacteria, Viruses, and Parasites
- (2012) Johnny X. Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The future of antibodies as cancer drugs
- (2012) Janice M. Reichert et al. DRUG DISCOVERY TODAY
- Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
- (2011) Ralph A. Francescone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
- (2011) M. Faibish et al. MOLECULAR CANCER THERAPEUTICS
- Beyond natural antibodies: the power of in vitro display technologies
- (2011) Andrew R M Bradbury et al. NATURE BIOTECHNOLOGY
- Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer
- (2011) M Kawada et al. ONCOGENE
- Phage display: Concept, innovations, applications and future
- (2010) Jyoti Pande et al. BIOTECHNOLOGY ADVANCES
- Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion
- (2010) Gunjan Malik et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started